Page last updated: 2024-10-25

cimetidine and Plasma Cell Tumor

cimetidine has been researched along with Plasma Cell Tumor in 2 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Ness, J1
Laemmli, UK1
Pettijohn, DE1
Gorczynski, RM1
Kennedy, M1
Ciampi, A1

Other Studies

2 other studies available for cimetidine and Plasma Cell Tumor

ArticleYear
Immunization in vitro and production of monoclonal antibodies specific to insoluble and weakly immunogenic proteins.
    Proceedings of the National Academy of Sciences of the United States of America, 1984, Volume: 81, Issue:24

    Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Complex; B-Lymphocytes; Cell Line; Cimetidine; Epi

1984
Cimetidine reverses tumor growth enhancement of plasmacytoma tumors in mice demonstrating conditioned immunosuppression.
    Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:6

    Topics: Animals; Cimetidine; Conditioning, Classical; Cyclophosphamide; Drinking Behavior; Female; Histamine

1985